Life Expectancy Consideration

Life Expectancy Consideration is a clinical decision-making construct in oncology that integrates individualized prognostic estimates to guide deprescribing by distinguishing treatments likely to exceed the patient’s remaining lifespan from those aligned with palliative goals and expected survival.

452

Publications

32.4K

Citations

2.1K

Authors

866

Institutions

Publications per year

2017–2026

113

Authors

2.1K

  1. CE
    Craig Evan Pollack

    Johns Hopkins University, United States

    11 publications · 452 citations

    11

    h-index

  2. NL
    Nancy L. Schoenborn

    Johns Hopkins University, United States

    10 publications · 401 citations

    10

    h-index

  3. CM
    Cynthia M. Boyd

    Johns Hopkins University, United States

    10 publications · 401 citations

    10

    h-index

  4. DS
    Deborah Schrag

    Dana-Farber Cancer Institute, United States

    5 publications · 2.3K citations

    6

    h-index

  5. RS
    R. Scott Braithwaite

    New York University, United States

    5 publications · 258 citations

    5

    h-index

1–5 of 2.1K

Venues

  1. PubMed

    Repository · 32 publications · 1.1K citations

    18

    h-index

  2. Journal of Clinical Oncology

    16 publications · 2.5K citations

    15

    h-index

  3. Annals of Internal Medicine

    13 publications · 1.4K citations

    13

    h-index

  4. JAMA

    11 publications · 2.4K citations

    10

    h-index

  5. Medical Decision Making

    MDM · 10 publications · 249 citations

    10

    h-index

1–5